<qa>  What is the primary purpose of this study?The primary purpose of this study is to evaluate the impact of dapagliflozin, as compared with placebo, on heart failure disease-specific biomarkers, symptoms, health status, and quality of life in patients with type 2 diabetes and chronic heart failure with reduced systolic function. 